166 related articles for article (PubMed ID: 36344176)
21. Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposes.
Montironi R; Ball RY; Griffiths DF; Grigor K; Harnden PM; Jarmulowicz M; McWilliam LJ; Moseley RP; Parkinson MC; Santinelli A; Moss SM; Melia JW
Anal Quant Cytol Histol; 2008 Feb; 30(1):8-15. PubMed ID: 18459582
[TBL] [Abstract][Full Text] [Related]
22. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.
Kryvenko ON; Epstein JI
Arch Pathol Lab Med; 2016 Oct; 140(10):1140-52. PubMed ID: 26756649
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors.
Meliti A; Sadimin E; Diolombi M; Khani F; Epstein JI
Prostate; 2017 May; 77(6):681-685. PubMed ID: 28155999
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
[No Abstract] [Full Text] [Related]
25. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
[TBL] [Abstract][Full Text] [Related]
26. Grading of prostatic adenocarcinoma: current state and prognostic implications.
Gordetsky J; Epstein J
Diagn Pathol; 2016 Mar; 11():25. PubMed ID: 26956509
[TBL] [Abstract][Full Text] [Related]
27. The present and future of prostate cancer histopathology.
McKenney JK
Curr Opin Urol; 2017 Sep; 27(5):464-468. PubMed ID: 28614086
[TBL] [Abstract][Full Text] [Related]
28. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case No. 8: Acinar prostatic adenocarcinoma, Gleason score 6 (3+3)].
Ferlicot S
Ann Pathol; 2017 Jun; 37(3):259-263. PubMed ID: 28522121
[No Abstract] [Full Text] [Related]
29. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
[TBL] [Abstract][Full Text] [Related]
30. Inter/intra-observer reproducibility of Gleason scoring in prostate adenocarcinoma in Iranian pathologists.
Abdollahi A; Meysamie A; Sheikhbahaei S; Ahmadi A; Moradi-Tabriz H; Bakhshandeh M; Hosseinzadeh H
Urol J; 2012; 9(2):486-90. PubMed ID: 22641492
[TBL] [Abstract][Full Text] [Related]
31. An update of the Gleason grading system.
Epstein JI
J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
[TBL] [Abstract][Full Text] [Related]
32. Prostatic Adenocarcinoma: A Grading from Gleason to the New Grade-Group System: A Historical and Critical Review.
Barakzai MA
Asian Pac J Cancer Prev; 2019 Mar; 20(3):661-666. PubMed ID: 30909661
[TBL] [Abstract][Full Text] [Related]
33. Inter-observer reproducibility before and after web-based education in the Gleason grading of the prostate adenocarcinoma among the Iranian pathologists.
Abdollahi A; Sheikhbahaei S; Meysamie A; Bakhshandeh M; Hosseinzadeh H
Acta Med Iran; 2014; 52(5):370-4. PubMed ID: 24902017
[TBL] [Abstract][Full Text] [Related]
34. Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.
Hechtman JF; Xiao GQ; Unger PD; Kinoshita Y; Godbold JH; Burstein DE
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):344-9. PubMed ID: 22417861
[TBL] [Abstract][Full Text] [Related]
35. Intraductal carcinoma of the prostate: a critical re-appraisal.
Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
[TBL] [Abstract][Full Text] [Related]
36. Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists.
Renshaw AA; Schultz D; Cote K; Loffredo M; Ziemba DE; D'Amico AV
Arch Pathol Lab Med; 2003 Aug; 127(8):1007-8. PubMed ID: 12873176
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system.
Shah RB; Tadros Y
Hum Pathol; 2014 Nov; 45(11):2263-9. PubMed ID: 25228336
[TBL] [Abstract][Full Text] [Related]
38. Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Compérat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJ
Histopathology; 2016 Sep; 69(3):441-9. PubMed ID: 27028587
[TBL] [Abstract][Full Text] [Related]
39. Not all gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series.
Siadat F; Sykes J; Zlotta AR; Aldaoud N; Egawa S; Pushkar D; Kuk C; Bristow RG; Montironi R; van der Kwast T
Prostate; 2015 Sep; 75(12):1277-84. PubMed ID: 25963383
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland.
O'Kelly F; Elamin S; Cahill A; Aherne P; White J; Buckley J; O'Regan KN; Brady A; Power DG; O'Brien MF; Sweeney P; Mayer N; Kelly PJ
World J Urol; 2014 Aug; 32(4):1067-74. PubMed ID: 24129893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
